Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

In vitro characterization of odorranalectin for peptide-based drug delivery across the blood-brain barrier.

Sajja RK, Cudic P, Cucullo L.

BMC Neurosci. 2019 May 8;20(1):22. doi: 10.1186/s12868-019-0504-x.

2.

Targeting cancer-specific glycans by cyclic peptide lectinomimics.

Rodriguez MC, Yongye AB, Cudic M, Martinez Mayorga K, Liu E, Mueller BM, Ainsley J, Karabencheva-Christova T, Christov CZ, Cudic M, Cudic P.

Amino Acids. 2017 Nov;49(11):1867-1883. doi: 10.1007/s00726-017-2485-3. Epub 2017 Sep 11.

3.

Antibacterial and Antibiofilm Activities of a Novel Synthetic Cyclic Lipopeptide against Cariogenic Streptococcus mutans UA159.

Min KR, Galvis A, Williams B, Rayala R, Cudic P, Ajdic D.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00776-17. doi: 10.1128/AAC.00776-17. Print 2017 Aug.

4.

Identification of activators of methionine sulfoxide reductases A and B.

Cudic P, Joshi N, Sagher D, Williams BT, Stawikowski MJ, Weissbach H.

Biochem Biophys Res Commun. 2016 Jan 22;469(4):863-7. doi: 10.1016/j.bbrc.2015.12.077. Epub 2015 Dec 21.

5.

Identification of novel cyclic lipopeptides from a positional scanning combinatorial library with enhanced antibacterial and antibiofilm activities.

Bionda N, Fleeman RM, de la Fuente-Núñez C, Rodriguez MC, Reffuveille F, Shaw LN, Pastar I, Davis SC, Hancock REW, Cudic P.

Eur J Med Chem. 2016 Jan 27;108:354-363. doi: 10.1016/j.ejmech.2015.11.032. Epub 2015 Nov 30.

6.

Development of second generation peptides modulating cellular adiponectin receptor responses.

Otvos L Jr, Knappe D, Hoffmann R, Kovalszky I, Olah J, Hewitson TD, Stawikowska R, Stawikowski M, Cudic P, Lin F, Wade JD, Surmacz E, Lovas S.

Front Chem. 2014 Oct 17;2:93. doi: 10.3389/fchem.2014.00093. eCollection 2014.

7.

The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor.

Otvos L Jr, Vetter SW, Koladia M, Knappe D, Schmidt R, Ostorhazi E, Kovalszky I, Bionda N, Cudic P, Surmacz E, Wade JD, Hoffmann R.

Amino Acids. 2014 Apr;46(4):873-82. doi: 10.1007/s00726-013-1650-6. Epub 2013 Dec 24.

PMID:
24366600
8.

In vitro and in vivo activities of novel cyclic lipopeptides against staphylococcal biofilms.

Bionda N, Pastar I, Davis SC, Cudic P.

Protein Pept Lett. 2014 Apr;21(4):352-6.

PMID:
24164269
9.

Dissociation of antimicrobial and hemolytic activities of gramicidin S through N-methylation modification.

Li Y, Bionda N, Yongye A, Geer P, Stawikowski M, Cudic P, Martinez K, Houghten RA.

ChemMedChem. 2013 Nov;8(11):1865-72. doi: 10.1002/cmdc.201300232. Epub 2013 Sep 10.

PMID:
24023000
10.

Solid-phase guanidinylation of peptidyl amines compatible with standard Fmoc-chemistry: formation of monosubstituted guanidines.

Bionda N, Cudic P.

Methods Mol Biol. 2013;1081:151-65. doi: 10.1007/978-1-62703-652-8_10.

PMID:
24014439
11.

Synthesis of side chain N,N'-diaminoalkylated derivatives of basic amino acids for application in solid-phase peptide synthesis.

Pitteloud JP, Bionda N, Cudic P.

Methods Mol Biol. 2013;1081:61-75. doi: 10.1007/978-1-62703-652-8_5.

PMID:
24014434
12.

Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria.

Bionda N, Pitteloud JP, Cudic P.

Future Med Chem. 2013 Jul;5(11):1311-30. doi: 10.4155/fmc.13.86. Review.

13.

Effect of ester to amide or N-methylamide substitution on bacterial membrane depolarization and antibacterial activity of novel cyclic lipopeptides.

Bionda N, Fleeman RM, Shaw LN, Cudic P.

ChemMedChem. 2013 Aug;8(8):1394-402. doi: 10.1002/cmdc.201300173. Epub 2013 Jun 18.

14.

Solid-phase synthesis of fusaricidin/LI-F class of cyclic lipopeptides: Guanidinylation of resin-bound peptidyl amines.

Bionda N, Pitteloud JP, Cudic P.

Biopolymers. 2013 Apr;100(2):160-6. doi: 10.1002/bip.22186.

15.

Direct access to side chain N,N'-diaminoalkylated derivatives of basic amino acids suitable for solid-phase peptide synthesis.

Pitteloud JP, Bionda N, Cudic P.

Amino Acids. 2013 Feb;44(2):321-33. doi: 10.1007/s00726-012-1336-5. Epub 2012 Jun 20.

PMID:
22714010
16.

Effects of cyclic lipodepsipeptide structural modulation on stability, antibacterial activity, and human cell toxicity.

Bionda N, Stawikowski M, Stawikowska R, Cudic M, López-Vallejo F, Treitl D, Medina-Franco J, Cudic P.

ChemMedChem. 2012 May;7(5):871-82. doi: 10.1002/cmdc.201200016. Epub 2012 Mar 5.

17.

A practical synthesis of N α-Fmoc protected L-threo-β-hydroxyaspartic acid derivatives for coupling via α- or β-carboxylic group.

Bionda N, Cudic M, Barisic L, Stawikowski M, Stawikowska R, Binetti D, Cudic P.

Amino Acids. 2012 Jan;42(1):285-93. doi: 10.1007/s00726-010-0806-x. Epub 2010 Nov 17.

PMID:
21082204
18.

Bicyclic organo-peptides as models for carbohydrate binding proteins.

James-Johnson C, Cudic P.

Adv Exp Med Biol. 2009;611:593-4. No abstract available.

PMID:
19400325
19.

Agonists and partial antagonists acting on the leptin--leptin receptor interface.

Otvos L Jr, Cassone M, Terrasi M, Cascio S, Mateo GD, Knappe D, Hoffmann R, Cudic P, Wade JD, Surmacz E.

Adv Exp Med Biol. 2009;611:497-8. No abstract available.

PMID:
19400282
20.

Progress toward total solid-phase synthesis of depsipeptide antibiotic katanosin B.

Stawikowska R, Stawikowski M, Cudic P.

Adv Exp Med Biol. 2009;611:385-6. No abstract available.

PMID:
19400235
21.

Lipodepsipeptide antibiotic fusaricidin and its analogues. Total solid-phase and biological activity.

Stawikowski M, Cudic P.

Adv Exp Med Biol. 2009;611:383-4. No abstract available.

PMID:
19400234
22.

Synergy between a lead proline-rich antibacterial peptide derivative and small molecule antibiotics.

Otvos L Jr, Cassone M, Inacio VO, Noto P, Rux JJ, Wade JD, Cudic P.

Adv Exp Med Biol. 2009;611:375-8. No abstract available.

PMID:
19400232
23.

Peptidomimetics: Fmoc solid-phase pseudopeptide synthesis.

Cudic P, Stawikowski M.

Methods Mol Biol. 2008;494:223-46. doi: 10.1007/978-1-59745-419-3_13.

PMID:
18726577
24.

Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics.

Cassone M, Vogiatzi P, La Montagna R, De Olivier Inacio V, Cudic P, Wade JD, Otvos L Jr.

Peptides. 2008 Nov;29(11):1878-86. doi: 10.1016/j.peptides.2008.07.016. Epub 2008 Aug 5.

PMID:
18721837
25.

Depsipeptide synthesis.

Stawikowski M, Cudic P.

Methods Mol Biol. 2007;386:321-39. doi: 10.1007/978-1-59745-430-8_13.

PMID:
18604953
26.

Development of a pharmacologically improved peptide agonist of the leptin receptor.

Otvos L Jr, Terrasi M, Cascio S, Cassone M, Abbadessa G, De Pascali F, Scolaro L, Knappe D, Stawikowski M, Cudic P, Wade JD, Hoffmann R, Surmacz E.

Biochim Biophys Acta. 2008 Oct;1783(10):1745-54. doi: 10.1016/j.bbamcr.2008.05.007. Epub 2008 May 21.

27.

A novel strategy for the solid-phase synthesis of cyclic lipodepsipeptides.

Stawikowski M, Cudic P.

Tetrahedron Lett. 2006 Nov 27;47(48):8587-8590.

28.

Prior antibacterial peptide-mediated inhibition of protein folding in bacteria mutes resistance enzymes.

Otvos L Jr, de Olivier Inacio V, Wade JD, Cudic P.

Antimicrob Agents Chemother. 2006 Sep;50(9):3146-9.

29.

Chemistry and biology of the ramoplanin family of peptide antibiotics.

McCafferty DG, Cudic P, Frankel BA, Barkallah S, Kruger RG, Li W.

Biopolymers. 2002;66(4):261-84. Review.

PMID:
12491539
30.

Functional analysis of the lipoglycodepsipeptide antibiotic ramoplanin.

Cudic P, Behenna DC, Kranz JK, Kruger RG, Wand AJ, Veklich YI, Weisel JW, McCafferty DG.

Chem Biol. 2002 Aug;9(8):897-906.

31.

Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: minimal structural requirements for intermolecular complexation and fibril formation.

Cudic P, Kranz JK, Behenna DC, Kruger RG, Tadesse H, Wand AJ, Veklich YI, Weisel JW, McCafferty DG.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7384-9.

32.

Synthesis of P(1)-Citronellyl-P(2)-alpha-D-pyranosyl pyrophosphates as potential substrates for the E. coli undecaprenyl-pyrophosphoryl-N-acetylglucoseaminyl transferase MurG.

Cudic P, Behenna DC, Yu MK, Kruger RG, Szewczuk LM, McCafferty DG.

Bioorg Med Chem Lett. 2001 Dec 17;11(24):3107-10.

PMID:
11720853
33.

Synergy and duality in peptide antibiotic mechanisms.

McCafferty DG, Cudic P, Yu MK, Behenna DC, Kruger R.

Curr Opin Chem Biol. 1999 Dec;3(6):672-80. Review.

PMID:
10600730

Supplemental Content

Support Center